September 5 , 2023 : Merck, a leading biopharmaceutical company, announced today that it will participate in the Morgan Stanley 21st Annual Global Healthcare Conference. The conference will be held in New York City on September 11-12, 2023.
Caroline Litchfield, executive vice president and chief financial officer, and Dr. Dean Y. Li, executive vice president and president of Merck Research Laboratories, will participate in a fireside chat at the conference. The discussion will begin at 2:15 p.m. EDT on Monday, September 11.
In the fireside chat, Litchfield and Li will discuss Merck’s financial performance, its pipeline of innovative medicines and vaccines, and its commitment to advancing science to improve lives. They will also answer questions from investors and analysts.
The Morgan Stanley 21st Annual Global Healthcare Conference is one of the premier healthcare conferences in the world. It brings together investors, analysts, and healthcare executives to discuss the latest trends and developments in the industry.
Merck’s participation in the conference is an opportunity for the company to share its vision for the future of healthcare and to engage with investors and analysts about its plans.